Marimed (MRMD) Operating Income Growth (1y) (2012 - 2026)
Marimed (MRMD) Operating Income Growth (1y) (2012 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Op. Inc Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 89.60 Bn | 87.73 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 35.81 Bn | 32.07 Bn | 1.97 Bn | 25.63% |
| 3 | Zoetis | 32.47 Bn | 30.53 Bn | 1.62 Bn | -1.30% |
| 4 | Takeda Pharmaceutical | 27.55 Bn | 23.49 Bn | 4.39 Bn | -319.32% |
| 5 | United Therapeutics | 23.10 Bn | 20.95 Bn | 648.10 Mn | -14.89% |
| 6 | RedHill Biopharma | 21.48 Bn | 21.48 Bn | - | - |
| 7 | Viatris | 20.31 Bn | 18.50 Bn | 1.16 Bn | 97.23% |
| 8 | Neurocrine Biosciences | 17.77 Bn | 16.46 Bn | 800.70 Mn | 719.49% |
| 9 | Elanco Animal Health | 12.61 Bn | 12.18 Bn | 785.00 Mn | 21.25% |
| 10 | Marimed | 25.72 Mn | 17.78 Mn | 15.28 Mn | 113.74% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 113.74% |
| Dec 31, 2025 | -208.24% |
| Sep 30, 2025 | 18.88% |
| Jun 30, 2025 | 19.35% |
| Mar 31, 2025 | -145.03% |
| Dec 31, 2024 | -160.89% |
| Sep 30, 2024 | -59.14% |
| Jun 30, 2024 | -73.05% |
| Mar 31, 2024 | -60.64% |
| Dec 31, 2023 | -21.95% |
| Sep 30, 2023 | -42.61% |
| Jun 30, 2023 | -21.09% |
| Mar 31, 2023 | -27.15% |
| Dec 31, 2022 | 156.77% |
| Sep 30, 2022 | -13.35% |
| Jun 30, 2022 | -62.55% |
| Mar 31, 2022 | 0.16% |
| Dec 31, 2021 | -85.04% |
| Sep 30, 2021 | 94.81% |
| Jun 30, 2021 | 471.72% |